Metal-protein adduct

Metal-protein adducts are the primary antigenic entities responsible for triggering Allergic Contact Dermatitis (ACD), a prevalent Type IV hypersensitivity reaction. These adducts form when metallic haptens—most commonly nickel, cobalt, or chromium—interact with endogenous skin proteins such as human serum albumin, keratins, or filaggrin (Martin, 2011). The metal ions act as haptens, binding to specific amino acid residues (often histidine or cysteine) to create a neoantigen that can be processed and presented by Langerhans cells and other dendritic cells via MHC Class I or II molecules (Thierse et al., 2005). In some instances, metals like nickel can directly activate Toll-like receptor 4 (TLR4), providing the necessary costimulatory signals for a robust immune response (Schmidt et al., 2010). The clinical manifestation of these adducts is driven by the activation of skin-resident memory T-cells, which rapidly proliferate and secrete pro-inflammatory cytokines like IFN-gamma, IL-17, and TNF-alpha upon re-exposure to the metal (Ahlström et al., 2019). While the metal-protein adduct itself is the initiator, therapeutic intervention typically targets the downstream inflammatory cascade using corticosteroids or calcineurin inhibitors (Esser et al., 2012).

Other names

Hapten-protein complexMetal-haptenated proteinAntigenic metal complexMetal-protein conjugate

Inhibition of T-cell activation and pro-inflammatory cytokine production (e.g., IL-17, IFN-gamma) to suppress the Type IV hypersensitivity response initiated by the adduct.